Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000875320-07-000081
Filing Date
2007-07-18
Accepted
2007-07-18 13:25:25
Documents
1
Period of Report
2007-07-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2434
  Complete submission text file 0000875320-07-000081.txt   4161
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139
Business Address 617-444-6100
Graves Kurt (Reporting) CIK: 0001406337 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19319 | Film No.: 07986124